Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Controlled Release

• Publication date

  2016-02-28

• Fields of study

  Biology, Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2016.01.021PMID 26774218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment

  2014cited by this paper
• Time to deliver

  2014cited by this paper
• Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation

  2014cited by this paper
• Engineered nanoparticles for drug delivery in cancer therapy.

  2014cited by this paper
• Sigma‐2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy

  2014cited by this paper
• Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.

  2014cited by this paper
• Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery.

  2014cited by this paper
• Precise Engineering of Multifunctional PEGylated Polyester Nanoparticles for Cancer Cell Targeting and Imaging

  2014cited by this paper
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

  2014cited by this paper
• Breakthrough discoveries in drug delivery technologies: the next 30 years.

  2014cited by this paper
• Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.

  2013cited by this paper
• Regulation of macrophage immune responses by antipsychotic drugs

  2013cited by this paper
• Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy.

  2013cited by this paper
• Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles.

  2013cited by this paper
• The σ2 receptor: a novel protein for the imaging and treatment of cancer.

  2013cited by this paper
• Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model.

  2013cited by this paper
• Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate.

  2013cited by this paper
• Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis.

  2013cited by this paper
• Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

  2012cited by this paper
• Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.

  2012cited by this paper
• Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.

  2012cited by this paper
• Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy

  2012cited by this paper
• Nanoparticle delivery of a peptide targeting EGFR signaling.

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.

  2011cited by this paper
• Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.

  2010cited by this paper
• Haloperidol disrupts lipid rafts and impairs insulin signaling in SH-SY5Y cells.

  2010cited by this paper
• Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery.

  2010cited by this paper
• Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment.

  2010cited by this paper
• The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls.

  2010cited by this paper
• Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts.

  2010cited by this paper
• Haloperidol disrupts Akt signalling to reveal a phosphorylation-dependent regulation of pro-apoptotic Bcl-XS function.

  2009cited by this paper
• Active targeting schemes for nanoparticle systems in cancer therapeutics.

  2008cited by this paper
• Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands

  2008cited by this paper
• Multifunctional magnetic nanoparticles for targeted imaging and therapy.

  2008cited by this paper
• Cytotoxicity of σ-Receptor Ligands Is Associated with Major Changes of Cellular Metabolism and Complete Occupancy of the σ-2 Subpopulation

  2008cited by this paper
• An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.

  2008cited by this paper
• Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles.

  2008cited by this paper
• σ Receptors: Historical Perspective and Background

  2007cited by this paper
• Irreversible blockade of sigma‐1 receptors by haloperidol and its metabolites in guinea pig brain and SH‐SY5Y human neuroblastoma cells

  2007cited by this paper
• The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines.

  2006cited by this paper
• Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events

  2006cited by this paper
• Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS

  2006cited by this paper
• Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS.

  2006cited by this paper
• Time to deliver

  2006cited by this paper
• Sodium ascorbate (vitamin C) induces apoptosis in melanoma cells via the down‐regulation of transferrin receptor dependent iron uptake

  2005cited by this paper
• Sigma Receptors and Cancer

  2004cited by this paper
• Anisamide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells

  2004cited by this paper
• Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells.

  2003cited by this paper
• σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export

  2003cited by this paper
• Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export.

  2003cited by this paper
• Intracellular Dynamics of σ-1 Receptors (σ1 Binding Sites) in NG108-15 Cells

  2003cited by this paper
• Folate-mediated delivery of macromolecular anticancer therapeutic agents.

  2002cited by this paper
• The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.

  2002cited by this paper
• Regulating ankyrin dynamics: Roles of sigma-1 receptors.

  2001cited by this paper
• Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors

  2000cited by this paper
• Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.

  1999cited by this paper
• Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.

  1999cited by this paper
• Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level.

  1999cited by this paper
• Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

  1996cited by this paper
• Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).

  1996cited by this paper
• Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability

  1995cited by this paper
• Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

  1995cited by this paper
• [3H](+)-Pentazocine binding to rat brain σ1 receptors

  1994cited by this paper
• sigma recognition sites in brain and peripheral tissues. Characterization and effects of cytochrome P450 inhibitors.

  1994cited by this paper
• [3H](+)-pentazocine binding to rat brain sigma 1 receptors.

  1994cited by this paper
• Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.

  1991cited by this paper

• pH-Responsive Resveratrol Liposomes Targeting Sigma1 Receptor Attenuate Renal Fibrosis by Remodeling the Renal Microenvironment.

  2026cites this paper
• Receptor-targeted metal-organic frameworks: Recent progress in synthesis, modifications, and applications in targeted drug delivery.

  2025cites this paper
• Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy

  2024cites this paper
• Nucleic Acid Conjugates: Unlocking Therapeutic Potential

  2024cites this paper
• Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis.

  2024cites this paper
• Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy.

  2023cites this paper
• Rapid Microwave-Assisted Synthesis of pH-Sensitive Carbon-Based Nanoparticles for the Controlled Release of Doxorubicin to Cancer Cells

  2023cites this paper
• Tumor associated fibroblasts-targeting nanoparticles for enhancing solid tumor therapy: progresses and challenges

  2022cites this paper
• Tumor targeting strategies by chitosan-based nanocarriers

  2022cites this paper
• Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.

  2021cites this paper
• Targeting Solid Lipid Nanoparticles with Anisamide for Docetaxel Delivery to Prostate Cancer: Preparation, Optimization, and In-vitro Evaluation

  2021cites this paper
• Emerging nano drug delivery systems targeting cancer-associated fibroblasts for improved anti-tumor effect and tumor drug penetration.

  2020cites this paper
• Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules

  2020cites this paper
• Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems.

  2019cites this paper
• Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems

  2019cites this paper
• Polymer Nanoplatforms at Work in Prostate Cancer Therapy

  2019cites this paper
• Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors.

  2019cites this paper
• Anisamide-Anchored Lyotropic Nano-Liquid Crystalline Particles with AIE Effect: A Smart Optical Beacon for Tumor Imaging and Therapy.

  2018cites this paper
• Novel liposomal combination treatments using dual genes knockdown in oral cancer treatment

  2018cites this paper
• Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging.

  2018cites this paper
• Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.

  2017cites this paper
• Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.

  2017cites this paper
• Targeting Nanocarriers with Anisamide: Fact or Artifact?

  2017cites this paper
• Targeted delivery of a guanidine-pendant Pt(iv)-backboned poly-prodrug by an anisamide-functionalized polypeptide.

  2017cites this paper
• Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.

  2017cites this paper
• Latest News on Nanotechnology for Melanoma Therapy and Diagnosis

  2016cites this paper
• Tumor targeting strategies for chitosan-based nanoparticles.

  2016cites this paper
• Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer - synthesis, physicochemical characterisation and in vitro evaluation.

  2016cites this paper
• On the article "Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles" [J. Control. Release 224 (2016) 229-238]: Letter to the Editor 1 (September 14, 2016).

  2016cites this paper